https://thepharmadata.com/merck-gains-positive-eu-chmp-opinion/ 2025-12-13T11:07:57+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Merck-Gains-Positive-EU-CHMP-Opinion-for-WINREVAIR™-Expansion-in-PAH.webp https://thepharmadata.com/aflibercept-8-mg-recommended-for-eu-approval/ 2025-12-13T11:18:36+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Aflibercept-8-mg-Recommended-for-EU-Approval-for-Third-Retinal-Indication_11zon.webp https://thepharmadata.com/cytokinetics-announces-positive-chmp-opinion/ 2025-12-15T10:56:07+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Cytokinetics-Announces-Positive-CHMP-Opinion-for-MYQORZO®-Aficamten-in-the-Treatment-of-Obstructive-Hypertrophic-Cardiomyopathy.webp https://thepharmadata.com/enhertu-pertuzumab-approved-as-first-new-1/ 2025-12-17T10:14:51+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Enhertu-Pertuzumab-Approved-as-First-New-1L-Treatment-in-10-Years-for-HER2-Metastatic-Breast-Cancer.webp https://thepharmadata.com/zoetis-proposes-1-75-billion-convertible/ 2025-12-17T10:18:03+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Zoetis-Proposes-1.75-Billion-Convertible-Senior-Notes-Offering.webp https://thepharmadata.com/uk-approves-exdensur-for-asthma-2-inflammation/ 2025-12-17T10:21:58+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/UK-Approves-Exdensur-Depemokimab-for-Asthma-with-Type-2-Inflammation-and-Chronic-Rhinosinusitis-with-Nasal-Polyps.webp https://thepharmadata.com/argenx-updates-on-uplighted-clinical-trials/ 2025-12-17T10:28:57+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Argenx-Updates-on-UplighTED-Clinical-Trials-of-Efgartigimod-SC-for-Thyroid-Eye-Disease.webp https://thepharmadata.com/grifols-secures-european-medicines-agency/ 2025-12-17T13:02:04+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Grifols-Secures-European-Medicines-Agency-Approval-for-Full-Value-Chain-of-Grifols-Egypt.webp https://thepharmadata.com/u-s-fda-approves-rybrevant-faspro-shortest/ 2025-12-18T10:52:33+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/U.S.-FDA-Approves-RYBREVANT-FASPRO™—Shortest-First-Line-Infusion-with-LAZCLUZE®.webp https://thepharmadata.com/keytruda-padcev-boost-survival-and-response/ 2025-12-18T10:56:12+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/KEYTRUDA-Padcev-Boost-Survival-and-Response-in-Cisplatin-Eligible-MIBC-Patients-Around-Surgery.webp https://thepharmadata.com/bluerocks-parkinsons-cell-therapy-gets-japans/ 2025-12-18T10:58:54+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/BlueRocks-Parkinsons-Cell-Therapy-Gets-Japans-Pioneering-Regenerative-Designation.webp https://thepharmadata.com/cdc-officially-endorses-delayed-hepatitis-b/ 2025-12-18T11:03:21+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/CDC-Officially-Endorses-Delayed-Hepatitis-B-Vaccine-Schedule.png https://thepharmadata.com/alnylam-to-invest-250m-in-u-s-facility/ 2025-12-18T11:07:31+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Alnylam-to-Invest-250M-in-U.S.-Facility-for-Enzymatic-Ligation-Platform.webp https://thepharmadata.com/incyte-announces-ec-approval-of-minjuvi/ 2025-12-18T11:15:42+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Incyte-Announces-EC-Approval-of-Minjuvi®-Tafasitamab-for-Relapsed-or-Refractory-Follicular-Lymphoma.webp https://thepharmadata.com/who-hosts-second-global-summit-to-advance/ 2025-12-18T11:23:13+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/WHO-Hosts-Second-Global-Summit-to-Advance-Evidence-Integration-and-Innovation-in-Traditional-Medicine.webp https://thepharmadata.com/lillys-orforglipron-sustains-weight-loss-after/ 2025-12-19T10:38:47+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Lillys-Orforglipron-Sustains-Weight-Loss-After-Switching-from-Injectable-to-Oral-GLP-1-Therapy-in-Phase-3-Trial.webp https://thepharmadata.com/novo-nordisk-seeks-fda-approval-for-cagrisema/ 2025-12-19T10:42:30+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Novo-Nordisk-Seeks-FDA-Approval-for-CagriSema—First-Once-Weekly-Combination-of-GLP-1-and-Amylin-Analogues-for-Weight-Management.webp https://thepharmadata.com/johnson-johnson-secures-fda-approval-trufill/ 2025-12-19T10:46:42+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/IDE034-a-Bispecific-Antibody-Drug-Conjugate-Licensed-by-Biocytogen-to-IDEAYA-Receives-FDA-IND-Clearance_11zon.webp https://thepharmadata.com/takedas-zasocitinib-shows-promise-in-phase-3/ 2025-12-19T10:49:48+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Takedas-Zasocitinib-Shows-Promise-in-Phase-3-Psoriasis-Trial-as-Once-Daily-Pill-for-Clear-Skin.webp https://thepharmadata.com/biontech-completes-acquisition-of-curevac-n-v/ 2025-12-19T10:53:49+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/BioNTech-Completes-Acquisition-of-CureVac-N.V.-Including-Follow-on-Offering-to-Bolster-Leadership-in-mRNA-Innovation-1.webp https://thepharmadata.com/johnson-johnson-supports-hrs-registry/ 2025-12-20T10:10:13+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Johnson-Johnson-Supports-HRS-Registry-to-Enhance-Real-World-Evidence-in-Pulsed-Field-Ablation-PFA_11zon-1.webp https://thepharmadata.com/wp-content/uploads/2025/12/Johnson-Johnson.webp https://thepharmadata.com/merck-strikes-deal-with-u-s-government/ 2025-12-20T10:27:22+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Merck-Strikes-Deal-with-U.S.-Government-to-Broaden-Medicine-Access-and-Reduce-Costs-for-Americans_11zon.webp https://thepharmadata.com/wuxi-biologics-earns-top-a-ratings-from-cdp/ 2025-12-20T10:48:46+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/WuXi-Biologics-Earns-Top-A-Ratings-from-CDP-for-Climate-Change-and-Water-Security.webp https://thepharmadata.com/biomarin-to-acquire-amicus-therapeutics-in-4-8/ 2025-12-20T10:53:38+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/BioMarin-to-Acquire-Amicus-Therapeutics-in-4.8-Billion-Deal-Bolstering-Leadership-in-Rare-Diseases-and-Driving-Growth_11zon.webp https://thepharmadata.com/cytokinetics-announces-fda-approval-of-myqorzo/ 2025-12-20T11:09:54+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/pexels-anntarazevich-6358840_11zon.webp https://thepharmadata.com/novo-nordisks-wegovy-becomes-first-oral-glp-1/ 2025-12-23T11:01:00+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Novo-Nordisks-Wegovy®-Becomes-First-Oral-GLP-1-Approved-in-the-U.S.-for-Weight-Management.webp https://thepharmadata.com/ec-approves-tremfya-for-pediatric-plaque/ 2025-12-23T11:05:55+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/EC-Approves-TREMFYA®-for-Pediatric-Plaque-Psoriasis-—-First-IL-23-Inhibitor-for-Children.webp https://thepharmadata.com/fda-approves-subcutaneous-use-of-roches/ 2025-12-23T11:09:47+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/FDA-Approves-Subcutaneous-Use-of-Roches-Lunsumio-VELO™-for-Relapsed-or-Refractory-Follicular-Lymphoma.webp https://thepharmadata.com/pimicotinib-approved-in-china-as-first-systemic/ 2025-12-23T11:14:53+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Pimicotinib-Approved-in-China-as-First-Systemic-Therapy-for-Tenosynovial-Giant-Cell-Tumor.webp https://thepharmadata.com/japan-approves-finerenone-for-chronic-heart/ 2025-12-23T11:19:15+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Japan-Approves-Finerenone-for-Chronic-Heart-Failure-Treatment.webp https://thepharmadata.com/who-global-summit-sets-a-bold-vision-future/ 2025-12-23T11:20:48+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Most-Countries-Advance-on-Universal-Health-Coverage-but-Challenges-Persist-–-WHOWorld-Bank-1.webp https://thepharmadata.com/crispr-therapeutics-updates-on-zugo-cel-in/ 2025-12-23T11:24:48+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/CRISPR-Therapeutics-Updates-on-Zugo-cel-in-Autoimmune-Blood-Cancers.webp https://thepharmadata.com/johnson-johnson-acquires-halda-therapeutics/ 2025-12-31T10:14:34+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Johnson-Johnson-Acquires-Halda-Therapeutics-to-Advance-Next-Gen-Oral-Cancer-Therapies_11zon.webp https://thepharmadata.com/ironwood-pharmaceuticals-confirms-fy-2025/ 2026-01-05T12:45:00+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Ironwood-Pharmaceuticals-_2_.webp https://thepharmadata.com/wp-content/uploads/2026/01/Ironwood-Pharmaceuticals-1024x768.webp https://thepharmadata.com/orum-therapeutics-names-chad-may-chief-scientifi/ 2026-01-05T16:14:27+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Orum-Therapeutics.webp https://thepharmadata.com/wp-content/uploads/2026/01/Orum-Therapeutics-2-1024x682.webp https://thepharmadata.com/halozyme-skye-bioscience-enter-collaboration/ 2026-01-06T12:15:21+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Halozyme-and-Skye-Bioscience-Enter-Global-Collaboration-to-Assess-Nimacimab-with-ENHANZE-for-Obesity-Treatment-2.webp https://thepharmadata.com/wp-content/uploads/2026/01/Halozyme-and-Skye-Bioscience-Enter-Global-Collaboration-to-Assess-Nimacimab-with-ENHANZE-for-Obesity-Treatment-1024x682.jpg https://thepharmadata.com/natera-shares-updated-findings/ 2026-01-06T15:49:57+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Natera-Shares-Updated-Findings-From-the-ALTAIR-Clinical-Trial-at-ASCO-GI.webp https://thepharmadata.com/bayer-secures-breakthrough-therapy/ 2026-01-06T16:14:34+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Bayer-Secures-Breakthrough-Therapy-Designation-in-the-U.S.-and-China-for-Sevabertinib-in-HER2-Mutant-NSCLC.webp https://thepharmadata.com/takeda-and-protagonist-submit-nda-to-fda-for-rusfertide-in-polycythemia-vera-treatment/ 2026-01-06T16:27:24+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Takeda-and-Protagonist-Submit-NDA-to-FDA-for-Rusfertide-in-Polycythemia-Vera-Treatment.webp https://thepharmadata.com/japan-approves-exdensur-depemokimab-for-patients-with-severe-asthma-and-chronic-rhinosinusitis-with-nasal-polyps/ 2026-01-06T17:05:53+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Japan-Approves-Exdensur-depemokimab-for-Patients-with-Severe-Asthma-and-Chronic-Rhinosinusitis-with-Nasal-Polyps.webp https://thepharmadata.com/novo-nordisks-wegovy-oral-glp-1-for-adult-weight-loss-now-widely-available-across-the-u-s/ 2026-01-06T17:13:23+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Novo-Nordisks-Wegovy®-Oral-GLP-1-for-Adult-Weight-Loss-Now-Widely-Available-Across-the-U.S.webp https://thepharmadata.com/4moving-biotech-secures-fda-ind-clearance/ 2026-01-09T10:34:16+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/4Moving-Biotech-Secures-FDA-IND-Clearance-for-4P004_-Advancing-Disease-Modifying-Osteoarthritis-Trea.webp https://thepharmadata.com/bayer-and-souffle-therapeutics-partner/ 2026-01-09T10:55:24+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Bayer-and-Souffle-Therapeutics-Partner-on-Heart-Targeted-siRNA.webp https://thepharmadata.com/candid-therapeutics-plans-phase-2-autoimmune-t-cell-trials/ 2026-01-09T11:07:14+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Phase-2-studies-advance-following-encouraging-clinical-data-for-T-cell-engagers-in-autoimmune-diseas.webp https://thepharmadata.com/rick-r-suarez-appointed-u-s-president-and-head-of-biopharmaceuticals-unit/ 2026-01-09T11:14:29+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Rick-R.-Suarez-Appointed-U.S.-President-and-Head-of-BioPharmaceuticals-Unit-scaled-e1767937460873.webp https://thepharmadata.com/enanta-pharmaceuticals-updates-research-pipeline-and-development-strategy-for-2026/ 2026-01-09T11:24:42+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Enanta-Pharmaceuticals-Updates-Research-Pipeline-and-Development-Strategy-for-2026.webp https://thepharmadata.com/gordian-bio-announces-collaboration-with-pfizer-on-obesity-in-vivo-target-research/ 2026-01-09T12:29:03+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Gordian-Bio-Announces-Collaboration-with-Pfizer-on-Obesity-In-Vivo-Target-Research.webp https://thepharmadata.com/johnson-johnson-delivers-on-u-s-agreement/ 2026-01-09T12:48:47+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Johnson-_-Johnson-Delivers-on-U.S.webp https://thepharmadata.com/at-jpm26-policy-and-politics-take-center/ 2026-01-10T10:58:24+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/At-JPM26_-Policy-and-Politics.webp https://thepharmadata.com/university-of-pennsylvania-biontech-and-oup/ 2026-01-10T11:18:11+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/University-of-Pennsylvania_.webp https://thepharmadata.com/bcg-and-hippocratic-ai-form-strategic-alliance/ 2026-01-10T11:40:34+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/BCG-and-Hippocratic.webp https://thepharmadata.com/nvidia-and-lilly-launch-co-innovation-ai-lab/ 2026-01-13T11:00:40+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/NVIDIA-and-Lilly-Launch-Co-Innovation-AI-Lab-to-Transform-Drug-Discovery-in-the-AI-Era.webp https://thepharmadata.com/camzyos-bristol-myers-squibb-reports-positive-3/ 2026-01-13T11:01:58+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Bristol-Myers-Squibb-Highlights-Targeted-Protein-Degradation-Data-Including-CELMoD-Agents-at-EHA-2025_11zon.webp https://thepharmadata.com/spinraza-biogen-secures-european-commission/ 2026-01-13T11:05:27+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Biogen-Secures-European-Commission-Approval-for-High-Dose-SPINRAZA®-nusinersen-Regimen-in-Spinal-Muscular-Atrophy.webp https://thepharmadata.com/royalty-pharma-to-showcase-achievements/ 2026-01-13T11:17:11+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Royalty-Pharma.png https://thepharmadata.com/wuxi-biologics-secures-uk-mhra-gmp-certification/ 2026-01-13T11:13:54+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Incyte-Names-Bill-Meury-as-CEO-as-Herve-Hoppenot-Announces-Retirement-2-e1768283027896.webp https://thepharmadata.com/legend-biotech-showcases-business-developments/ 2026-01-13T11:16:10+05:30 https://thepharmadata.com/wp-content/uploads/2024/09/eClinical-Solutions-Pioneers-the-Future-of-Drug-Development-at-ENGAGE-2024-Conference.webp https://thepharmadata.com/tecvayli-monotherapy-shows-superior-survival/ 2026-01-16T15:33:16+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/TECVAYLI®-Monotherapy-Shows-Superior-Survival-vs-Standard-Care-in-Early-Relapsed-Heavily-Pretreated-Myeloma.png https://thepharmadata.com/johnson-johnson-launches-mobile-simulator-app/ 2026-01-16T15:48:03+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Johnson-Johnson-Launches-Mobile-Simulator-App-to-Empower-Breast-Augmentation-Patients.png https://thepharmadata.com/celltrion-unveils-drug-pipeline-and-u-s/ 2026-01-16T15:52:30+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Celltrion-Unveils-Drug-Pipeline-and-U.S.-Expansion-at-J.P.-Morgan-Conference.webp https://thepharmadata.com/neurocrine-shows-ingrezza-achieves-austedo/ 2026-01-16T15:49:07+05:30 https://thepharmadata.com/wp-content/uploads/2023/06/Tablets.webp https://thepharmadata.com/opdivo-yervoy-approved-in-taiwan-for-msi-h/ 2026-01-16T15:54:54+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Opdivo®-Approved-in-South-Korea-for-First-Line-Treatment-of-Unresectable-or-Metastatic-Urothelial-Carcinoma-1.webp https://thepharmadata.com/caplyta-shows-promise-for-remission-in-major/ 2026-01-17T10:31:03+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/CAPLYTA®-Shows-Promise-for-Remission-in-Major-Depressive-Disorder.jpg https://thepharmadata.com/abbvie-reports-phase-3-epcore-dlbcl-1-topline/ 2026-01-17T10:33:31+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/AbbVie-Reports-Phase-3-EPCORE®-DLBCL-1-Topline-Results-for-Epcoritamab-in-RR-DLBCL.webp https://thepharmadata.com/bayer-applauds-u-s-supreme-courts-decision/ 2026-01-17T10:35:26+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/Bayer-Reaffirms-2025-Outlook-Following-Strong-Start-to-the-Year.webp https://thepharmadata.com/shionogi-wins-health-minister-award/ 2026-01-20T15:43:44+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Shionogi-1.webp https://thepharmadata.com/enhertu-pertuzumab-validated-in-eu-for-first/ 2026-01-20T15:57:07+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/ENHERTU.webp https://thepharmadata.com/bioscience-association-manitoba-joins-premiers/ 2026-01-20T15:52:23+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Bioscience-1.webp https://thepharmadata.com/lillys-mirvetuximab-soravtansine-earns-fda/ 2026-01-23T12:21:06+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Lillys.webp https://thepharmadata.com/aspect-biosystems-and-novo-nordisk-advance/ 2026-01-23T12:35:20+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Aspect-2.webp https://thepharmadata.com/moderna-merck-5-year-data-show-sustained/ 2026-01-23T12:02:06+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Moderna.webp https://thepharmadata.com/bristol-myers-squibb-partners-microsoft/ 2026-01-23T12:06:14+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Bristol.webp https://thepharmadata.com/bayer-and-vanderbilt-university-medical/ 2026-01-23T12:15:43+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Bayer.webp https://thepharmadata.com/fda-awards-orphan-drug-designation-to-bluerock/ 2026-01-23T12:19:21+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Orphan-Drug.webp https://thepharmadata.com/trelegy-ellipta-gains-approval-in-china-adults/ 2026-01-26T11:21:02+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Trelegy-Ellipta-Gains-Approval-in-China-for-Adults-with-Uncontrolled-Asthma.png https://thepharmadata.com/gsks-rsv-vaccine-arexvy-european-approval-18/ 2026-01-27T17:18:53+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/GSK.webp https://thepharmadata.com/bayer-to-unveil-new-phase-iii-data-and-2026/ 2026-01-27T17:21:55+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Bayer-1.webp https://thepharmadata.com/biomarin-announces-proposed-private-offering/ 2026-01-27T17:25:46+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/BioMarin.webp https://thepharmadata.com/wuxi-biologics-hanchorbio-partner-on-next-gen/ 2026-01-27T17:24:52+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/WuXi-Biologics-1.webp https://thepharmadata.com/neurocrine-biosciences-launches-phase-2-trial/ 2026-01-27T17:30:00+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Neurocrine.webp https://thepharmadata.com/darzalex-faspro-quadruplet-approved-for/ 2026-01-28T12:55:46+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/DARZALEX.webp https://thepharmadata.com/icons-accellacare-site-network-enhances-oncolog/ 2026-01-28T13:04:27+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/ICONs.webp https://thepharmadata.com/teva-will-forte-partners-with-for-honestly-hd/ 2026-01-28T13:00:50+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Teva.webp https://thepharmadata.com/intellia-therapeutics-announces-fda-2-phase-3/ 2026-01-28T14:35:13+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Intellia.webp https://thepharmadata.com/litifilimab-earns-fda-breakthrough-designation/ 2026-01-30T09:59:47+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Litifilimab-Earns.webp https://thepharmadata.com/biontech-appoints-kylie-jimenez-as-chief-people/ 2026-01-30T10:02:11+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/BioNTech-Appoints-Kylie-Jimenez-as-Chief-People-Officer-to-Management-Board_11zon.webp https://thepharmadata.com/wuxi-biologics-and-sinorda-biomedicine-forge/ 2026-01-30T10:03:41+05:30 https://thepharmadata.com/wp-content/uploads/2024/12/WuXi-Biologics-Sino-Biopharm-Ink-Deal-for-Biologics-Discovery_11zon-1.webp https://thepharmadata.com/glaukos-announces-fda-approval-of-nda-supplement/ 2026-01-30T10:05:13+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Glaukos-Announces-FDA-Approval-of-NDA-Supplement-Permitting-Re-Administration-of-iDose®-TR.webp https://thepharmadata.com/rcems-new-film-promotes-a-specialty-to-be-proud-of-annualconference-2026/ 2026-01-29T18:52:00+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/RCEMs-new-film-promotes-a-specialty-to-be-proud-of-Annual.webp https://thepharmadata.com/lilly-chooses-pennsylvania-injectable-medicine/ 2026-01-31T09:59:29+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Lilly-Chooses-Pennsylvania-for-New-Injectable-Medicine-and-Device-Manufacturing-Facility_11zon.webp https://thepharmadata.com/wp-content/uploads/2026/01/Lilly_11zon.webp https://thepharmadata.com/chmp-grants-positive-opinion-for-akeegabrca1-2/ 2026-01-31T10:07:01+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/Johnson-Johnson-Urges-Shareholders-to-Reject-Tutanota-Mini-Tender-Offer_11zon.webp https://thepharmadata.com/astrazeneca-expands-weight-management-portfolio/ 2026-01-31T10:13:31+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/AstraZeneca-Expands-Weight-Management-Portfolio-via-Collaboration-with-CSPC-Pharmaceuticals_11zon.webp https://thepharmadata.com/finerenone-recommended-in-the-treating-lvef-%e2%89%a540/ 2026-01-31T10:25:55+05:30 https://thepharmadata.com/wp-content/uploads/2026/01/Finerenone-Recommended-in-the-EU-for-Treating-Heart-Failure-Patients-with-LVEF-≥40.webp https://thepharmadata.com/cagrisema-shows-1-91-hba1c-drop-14-2-weight/ 2026-02-03T10:18:16+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/CagriSema-Shows-1.91-HbA1c-Drop-14.2-Weight-Loss-in-REIMAGINE-2-Trial_11zon.webp https://thepharmadata.com/erleada-shows-51-lower-mortality-darolutamide/ 2026-02-03T10:26:01+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/ERLEADA®-Shows-51-Lower-Mortality-vs-Darolutamide-in-mCSPC-Real-World-24-Month-Analysis.webp https://thepharmadata.com/eylea-hd-8-mg-data-at-angiogenesis-2026/ 2026-02-03T10:34:58+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/EYLEA-HD®-8-mg-Data-at-Angiogenesis-2026-Highlight-Robust-Retinal-Disease-Profile.webp https://thepharmadata.com/phase-3-trial-of-fezolinetant-in-japan-reports/ 2026-02-03T10:46:38+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Phase-3-Trial-of-Fezolinetant-in-Japan-Reports-Positive-Topline-Results-for-Menopausal-Vasomotor-Symptoms-VMS_11zon.webp https://thepharmadata.com/wp-content/uploads/2026/02/Fezolinetant.jpg https://thepharmadata.com/bio-techne-launches-fully-defined-expand-3d/ 2026-02-03T10:56:54+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Bio-Techne-Launches-Fully-Defined-Synthetic-Solution-to-Expand-3D-Stem-Cell-and-Organoid-Culture-Portfolio_11zon.webp https://thepharmadata.com/fda-accepts-exelixis-nda-for-zanzalintinib/ 2026-02-03T11:12:36+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/FDA-Accepts-Exelixis-NDA-for-Zanzalintinib-Combo-in-Metastatic-Colorectal-Cancer_11zon.webp https://thepharmadata.com/wp-content/uploads/2026/02/Exelixis_11zon.webp https://thepharmadata.com/johnson-johnson-showcases-new-scientific/ 2026-02-04T10:32:49+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/fotorichter-laboratory-8895975_1280_11zon.webp https://thepharmadata.com/pfizers-monthly-ultra-long-acting-injectable-1/ 2026-02-04T10:45:21+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Pfizers-Monthly-Ultra-Long-Acting-Injectable-GLP-1-RA-Demonstrates-Sustained-Significant-Weight-Loss-in-Phase-2b-Trial.webp https://thepharmadata.com/bristol-myers-squibb-launches-change/ 2026-02-04T11:28:20+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Bristol-Myers-Squibb-Launches-Change-the-Target.-Change-Whats-Possible.-to-Address-Unmet-Needs-in-Cardiovascular-and-Thromboembolic-Care.webp https://thepharmadata.com/nubeqa-darolutamide-secures-third-approval/ 2026-02-04T11:38:19+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Nubeqa™-Darolutamide-Secures-Third-Approval-in-China-for-Treatment-of-Advanced-Prostate-Cancer-in-Men.webp https://thepharmadata.com/clarest-health-launches-clarest-at-home/ 2026-02-05T14:20:15+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Clarest-Health-e1770281404513.webp https://thepharmadata.com/hims-hers-introduces-multi-cancer-early-detect/ 2026-02-05T12:43:36+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Hims-_-Hers.webp https://thepharmadata.com/stelo-adds-new-smart-meal-logging-features-to/ 2026-02-05T12:52:11+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Stelo-Adds.webp https://thepharmadata.com/aya-locums-physician-assistant-recognized-as2025/ 2026-02-05T14:16:17+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Aya-Locums.jpg https://thepharmadata.com/fda-approves-hologics-aptima-hpv-assay/ 2026-02-05T14:28:17+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/FDA.webp https://thepharmadata.com/chinas-nmpa-approves-promegas-msi-diagnostic/ 2026-02-05T14:37:59+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Diagnostic.webp https://thepharmadata.com/leyden-labs-shows-feasibility-of-a-novel-antib/ 2026-02-05T14:50:30+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Leyden.webp https://thepharmadata.com/fujirebio-and-sysmex-launch-sales-partnership/ 2026-02-05T15:03:09+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Fujirebio.webp https://thepharmadata.com/insulet-introduces-omnipod-5-and-omnipod-discov/ 2026-02-06T12:15:14+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Insulet.webp https://thepharmadata.com/revvity-introduces-advanced-discovery-platforms/ 2026-02-06T12:24:19+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Revvity.webp https://thepharmadata.com/health-canada-authorizes-mirums-livmarli/ 2026-02-06T12:30:37+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Health-Canada.webp https://thepharmadata.com/press-ganey-and-compass-healthcare-publish/ 2026-02-06T12:40:10+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Press-Ganey.webp https://thepharmadata.com/hims-hers-adds-affordable-compounded/ 2026-02-06T12:46:57+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Hims-Hers-2.webp https://thepharmadata.com/magnus-medical-enrolls-first-patient-in-dod-fund/ 2026-02-06T12:54:56+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Magnus-Medical.webp https://thepharmadata.com/aop-healths-rapiblyk-landiolol-becomes/ 2026-02-06T14:12:23+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Healths.webp https://thepharmadata.com/serenity-mental-health-centers-introduces-tms/ 2026-02-06T14:20:24+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Serenity-Mental-1.webp https://thepharmadata.com/morgan-stanley-and-the-american-heart-ass/ 2026-02-06T14:28:15+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Morgan.webp https://thepharmadata.com/biotech-showcase-2026-highlighted-early-stage/ 2026-02-06T14:56:37+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Biotech-Showcase.webp https://thepharmadata.com/mainstay-medical-secures-exclusive-blue-cros/ 2026-02-06T16:15:26+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Mainstay-Medical-1.webp https://thepharmadata.com/supplemental-screening-program-celebrates-20/ 2026-02-06T16:22:16+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Supplemental.webp https://thepharmadata.com/applied-medical-wins-antitrust-jury-trial-agains/ 2026-02-07T15:39:34+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Applied-Medical.webp https://thepharmadata.com/celebrating-24-years-of-give-kids-a-smile/ 2026-02-07T15:54:44+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Smile.webp https://thepharmadata.com/rapid-medicals-distals-trial-shows-strong-resul/ 2026-02-07T16:31:49+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/DISTALS.webp https://thepharmadata.com/johnson-johnson-shares-early-omny-af-pilot/ 2026-02-07T17:02:38+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Johnson-Johnson.webp https://thepharmadata.com/dr-joseph-chang-unveils-expanded-edition/ 2026-02-07T17:11:29+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Dr.-Joseph.webp https://thepharmadata.com/roches-fenebrutinib-shows-first-ppms-disability/ 2026-02-09T16:49:36+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Roches-Fenebrutinib-Shows-First-PPMS-Disability-Reduction-in-Over-a-Decade.webp https://thepharmadata.com/fenebrutinib-by-genentech-marks-major-breakthrou/ 2026-02-10T10:26:25+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Fenebrutinib.webp https://thepharmadata.com/evinova-and-bristol-myers-squibb-partner-strateg/ 2026-02-10T10:38:24+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Evinova.webp https://thepharmadata.com/median-technologies-achieves-fda-clearance-for/ 2026-02-10T10:48:36+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Median.webp https://thepharmadata.com/ethris-and-dzif-form-strategic-partnership/ 2026-02-10T10:58:42+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Ethris.webp https://thepharmadata.com/zcg-backed-unimed-completes-acquisition/ 2026-02-10T11:32:01+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/ZCG-Backed.webp https://thepharmadata.com/eurofins-viracor-biopharma-broadens-its-bioanaly/ 2026-02-10T11:48:16+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Eurofins.webp https://thepharmadata.com/vectory-therapeutics-doses-first-participant-in/ 2026-02-10T11:56:27+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/VectorY.webp https://thepharmadata.com/bruker-introduces-intapharma-platform-to/ 2026-02-10T12:03:34+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/iNTApharma™.webp https://thepharmadata.com/estrella-immunopharma-showcases-updated-eb103/ 2026-02-10T12:11:42+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Estrella-e1770705598848.webp https://thepharmadata.com/bioaffinity-technologies-names-leading-pulmonary/ 2026-02-10T12:18:25+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/bioAffinity-e1770706091410.jpg https://thepharmadata.com/ge-healthcare-unveils-readyfix-solution-to/ 2026-02-10T12:25:21+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/GE-HealthCare.webp https://thepharmadata.com/nuvation-bio-launches-global-phase-3-sigma-idh1/ 2026-02-10T12:30:58+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Nuvation.webp https://thepharmadata.com/nextpoint-therapeutics-announces-clinical-debut/ 2026-02-10T12:41:58+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/NextPoint.webp https://thepharmadata.com/innovate-32-teams-up-with-trivette-osborne/ 2026-02-11T14:41:33+05:30 https://thepharmadata.com/wp-content/uploads/2025/04/Parse-Biosciences-Announces-Partnership-with-Japanese-Distributor-SCRUM-Inc.webp https://thepharmadata.com/coya-therapeutics-schedules-webinar-with-medical/ 2026-02-11T14:48:31+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Coya-Therapeutics.webp https://thepharmadata.com/butterfly-network-earns-govramp-and-tx-ramp/ 2026-02-11T14:56:12+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/GovRAMP.webp https://thepharmadata.com/hemosonics-quantra-system-selected-as-2026/ 2026-02-11T15:18:00+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/HemoSonics-e1770803232290.webp https://thepharmadata.com/videahealth-and-aspen-dental-execute-major/ 2026-02-11T15:23:11+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/VideaHealth.webp https://thepharmadata.com/medimpact-offers-humira-biosimilar-at-95-disco/ 2026-02-11T15:40:10+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Humira.webp https://thepharmadata.com/vida-health-adds-mash-to-cardiometabolic-care/ 2026-02-11T15:52:35+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/MASH.webp https://thepharmadata.com/aop-health-us-llc-secures-pharmaceutical/ 2026-02-11T15:58:09+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Healths.webp https://thepharmadata.com/1600-pharmacies-see-up-to-4x-revenue/ 2026-02-11T16:04:50+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Pharmacies.webp https://thepharmadata.com/synaptive-medical-forms-clinical-advisory/ 2026-02-11T16:09:43+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Synaptive.webp https://thepharmadata.com/new-sensodyne-clinical-repair-toothpaste/ 2026-02-11T16:16:56+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Sensodyne-Clinical.webp https://thepharmadata.com/zolls-new-zenix-monitor-defibrillator-receives/ 2026-02-11T16:22:14+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Zenix.webp https://thepharmadata.com/exelixis-releases-q4-and-fy2025-financial/ 2026-02-11T16:29:16+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Exelixis.webp https://thepharmadata.com/whoop-launches-advanced-labs-in/ 2026-02-12T12:32:23+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/WHOOP.webp https://thepharmadata.com/agilent-honors-boehringer-ingelheim-with-first/ 2026-02-12T12:42:54+05:30 https://thepharmadata.com/wp-content/uploads/2024/09/Novotech-Wins-2024-Best-Practices-Award-for-Biotech-CRO-Leadership.webp https://thepharmadata.com/nashbio-announces-leadership-appointments/ 2026-02-12T12:47:49+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Vertex-Announces-Financial-Results-for-Q2-2024_11zon.webp https://thepharmadata.com/thermo-fisher-scientific-partners-with-datavant/ 2026-02-12T12:53:21+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/image-5.jpg https://thepharmadata.com/owlet-partners-with-promptcare-to-expand/ 2026-02-12T13:00:37+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Owlet.png https://thepharmadata.com/atlas-oncology-partners-secures-28m-series/ 2026-02-12T14:37:51+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Morgan.webp https://thepharmadata.com/national-health-organizations-partner-with/ 2026-02-13T11:07:57+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/HealthTap-Expands-Diabetes-Care-Access-via-LillyDirect®-Partnership.webp https://thepharmadata.com/astrazeneca-awards-3-4-million-to-expand/ 2026-02-12T15:07:43+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/AstraZeneca.jpg https://thepharmadata.com/flatiron-health-appoints-new-leaders-for/ 2026-02-12T15:12:25+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/BioMarin-to-Acquire-Amicus-Therapeutics-in-4.8-Billion-Deal-Bolstering-Leadership-in-Rare-Diseases-and-Driving-Growth_11zon.webp https://thepharmadata.com/natus-sensory-acquires-therab-medical-to/ 2026-02-12T15:21:21+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Natus.webp https://thepharmadata.com/loyal-secures-100m-series-c-funding-to-advance/ 2026-02-13T11:07:18+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Loyal.webp https://thepharmadata.com/ahf-warns-florida-health-department-proposal/ 2026-02-12T16:04:06+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/AHF.webp https://thepharmadata.com/galderma-introduces-first-of-its-kind/ 2026-02-13T14:51:34+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Galderma.webp https://thepharmadata.com/iproov-dynamic-liveness-sets-industry-first/ 2026-02-13T14:54:55+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/iProov.webp https://thepharmadata.com/kalvista-pharmaceuticals-showcases-ekterly/ 2026-02-13T15:01:43+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/KalVista-1.webp https://thepharmadata.com/australian-breast-cancer-innovators-secure-27m/ 2026-02-13T15:10:04+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Australian.webp https://thepharmadata.com/rxerp-p-chip-corporation-partner-on-licensing/ 2026-02-13T15:16:00+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/RxERP.webp https://thepharmadata.com/corazon-columbia-heartsource-introduce/ 2026-02-13T15:40:30+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/KaliVir-Roche-Partner-to-Test-VET3-TGI-Tecentriq®-in-Advanced-Tumors.webp https://thepharmadata.com/arintra-slashes-coding-expenses-and-achieves/ 2026-02-14T10:19:19+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Arintra.png https://thepharmadata.com/promega-presents-breakthrough-cellular-target/ 2026-02-14T14:24:23+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Promega.webp https://thepharmadata.com/quantum-si-issues-inducement-grants-under/ 2026-02-14T14:32:47+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Quantum-Si.webp https://thepharmadata.com/genentech-highlights-breakthrough-phase-iii/ 2026-02-17T11:50:38+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Genentech.webp https://thepharmadata.com/ecco-data-highlight-remsima-scs-ability/ 2026-02-17T11:55:24+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/ECCO-Data.webp https://thepharmadata.com/worldwide-clinical-trials-finalizes-acquisition/ 2026-02-17T12:00:06+05:30 https://thepharmadata.com/wp-content/uploads/2025/04/CytoAgents-Completes-Cohort-1-Dose-Escalation-in-Phase-1B-Clinical-Trial-for-Cytokine-Release-Syndrome-Research.webp https://thepharmadata.com/decibio-consulting-unveils-data-report-oncology/ 2026-02-17T12:03:23+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/DeciBio-e1771309991423.webp https://thepharmadata.com/vb-spine-moves-to-secure-exclusive-rights-to/ 2026-02-17T12:07:53+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Spine.webp https://thepharmadata.com/newron-pharmaceuticals-obtains-up-to-eur-38/ 2026-02-17T12:20:55+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Newron-2.webp https://thepharmadata.com/regional-dermatology-partnerepiphany-dermatology/ 2026-02-17T12:25:59+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Regional-e1771311333796.webp https://thepharmadata.com/nuclera-leadxpro-collaborate/ 2026-02-18T10:37:47+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Nuclera-e1771391209798.webp https://thepharmadata.com/immunitybio-advances-regulatory-collaboration/ 2026-02-18T11:24:01+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Collaboration.webp https://thepharmadata.com/braftovi-regimen-from-pfizer-demonstrates/ 2026-02-18T11:37:50+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/BRAFTOVI.webp https://thepharmadata.com/fda-accepts-bristol-myers-squibbs-nda-for/ 2026-02-18T12:02:27+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/FDA-1.webp https://thepharmadata.com/nationsbenefits-and-kinney-drugs-expand/ 2026-02-18T15:38:05+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/NationsBenefits-1.webp https://thepharmadata.com/decipheras-tirabrutinib-nda-accepted/ 2026-02-18T15:53:09+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Tirabrutinib.webp https://thepharmadata.com/twist-bioscience-broadens-antibody-discovery/ 2026-02-18T16:29:47+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Twist-Bioscience.webp https://thepharmadata.com/janux-therapeutics-doses-first-patient-in-phase/ 2026-02-18T16:37:16+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Janux-Therapeutics.webp https://thepharmadata.com/new-study-highlights-flashpoint-therapeutics/ 2026-02-19T16:02:06+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Therapeutics-_2_-1.webp https://thepharmadata.com/gensight-biologics-expands-regulatory/ 2026-02-19T16:36:25+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/GenSight-Biologics.jpg https://thepharmadata.com/korsana-biosciences-launches-with-175-million/ 2026-02-19T16:36:03+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Korsana-Biosciences.webp https://thepharmadata.com/merck-and-mayo-clinic-partner-to-advance/ 2026-02-20T09:57:34+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Merck.webp https://thepharmadata.com/kalvistas-ekterly-added-as-first-line-treatmen/ 2026-02-19T16:50:44+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/KalVista-2.webp https://thepharmadata.com/spruce-biosciences-advances-ta-ert-program/ 2026-02-19T17:02:37+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Stoke-Therapeutics-Announces-Q3-2025-Results-Business-Update_11zon.webp https://thepharmadata.com/chartcheck-adaptive-deployment-expands/ 2026-02-19T17:09:12+05:30 https://thepharmadata.com/wp-content/uploads/2025/01/GSKu2019s-B7-H3-ADC-GSKu201927-Gains-FDA-Breakthrough-Designation-for-Osteosarcoma-2_11zon.webp https://thepharmadata.com/affinia-therapeutics-receives-ema-orphan/ 2026-02-19T17:17:55+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/Affinia.webp https://thepharmadata.com/enhertu-variation-application-accepted/ 2026-02-19T17:23:22+05:30 https://thepharmadata.com/wp-content/uploads/2026/02/ENHERTU.jpg